Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07539961Not yet recruiting
Randomised, open-label trial of famotidine in Calcific tendinitis (2 arms), sponsored by Dubrava University Hospital. Primary endpoint: Oxford Shoulder Score at 12 months. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07539961.